Historical Person
Motlalepula Gilbert Matsabisa
Gender: Male
A regional expert panel endorsed a phase III clinical trial protocol for candidate herbal products against COVID-19, without approving a product.
The panel also endorsed terms of reference for a data and safety monitoring board to review participant safety during trials.
The agreed protocol was intended to help African scientists generate comparable evidence under international clinical research standards.
Its endorsement applied to methods for testing potential therapies; safety and effectiveness remained to be established by research.
